Skip to main content
OpenTrials
Completed

NCT Number: NCT06865508

Photo Biomodulation Therapy for Alveolar Osteitis Recovery in Oral Contraceptive Users

does laser effect on alveolar osteitis recovery in oral contraceptive users ?

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Alveolar Osteitis Dry Socket Mouth Diseases Stomatognathic Diseases

Age range

25 year–40 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

physical therapy at Badr University in Cairo(BUC)

Cairo, 11829, Egypt

About this study

photo biomodulation therapy for alveolar osteitis recovery in oral contraceptive users

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

  • Inclusion Criteria:

Female patients aged 25-40 years. Currently using oral contraceptives for at least 3 months prior to participation.

Diagnosed with dry socket (alveolar osteitis) based on clinical criteria.

  • Exclusion Criteria:

Presence of systemic diseases (e.g., diabetes, immunodeficiency disorders). Smoking or tobacco use. Allergies to zinc oxide or other study materials. Use of antibiotics or anti-inflammatory medications within the last 2 weeks. Pregnancy or breastfeeding.

Treatment and study plan

Laser Therapy

Device

Laser therapy was administered using a low-level laser device with the following parameters: [ wavelength 980 nm810, power 500mw, and duration 90 seconds (30second for each 3 sides].

zinc oxide eugenol dressing.

Device

zinc oxide eugenol dressing.

Primary outcomes

  1. pain intensity by VAS

    Time frame: 4 weeks

    Pain intensity measured using a Visual Analog Scale (VAS) at day0, day7, day14 post-treatment.

  2. Socket volume .

    Time frame: 4 weeks

    measured using [specific measurement technique, volumetric analysis] at day0, day14 and 1-month post-treatment

Secondary outcomes

  1. Quality of life assessed

    Time frame: 4 weeks

    Quality of life assessed using the Oral Health Impact Profile (OHIP-5) questionnaire at day0, day7and day14 post-treatment.

Sponsors and collaborators

Lead sponsor

Badr University

Other

Registry information

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Mar 10, 2025
Registry last updated
Mar 10, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.